Fri, Mar 24, 2017 | updated 05:32 AM IST

Targeting estrogen receptor increases progression-free survival in advanced breast cancer

Updated: Oct 09, 2016 13:34 IST

Washington D.C.[USA], Oct. 9 (ANI): Fulvestrant significantly increases progression-free survival in women with positive advanced breast cancer, particularly those with less aggressive lower-volume disease, reports a recent research.

Fulvestrant is a selective estrogen receptor degrader that targets the function of the hormone receptor so, unlike aromatase inhibitors such as anastrozole, it does not interfere with estrogen levels themselves.

The randomized, double-blind, multi-center phase III trial enrolled 462 women with inoperable locally-advanced or metastatic ER-positive, HER-negative breast cancer, who had not received prior hormone therapy.

Half the patients (n=230) were randomized to 500mg intramuscular injections of fulvestrant (Days 0, 14, 28, then every 28 days), or to 1mg of anastrozole daily (n=232), and were also allowed one line of chemotherapy.

After a median follow-up of 25 months, patients treated with fulvestrant had a statistically significant 21 percent improvement in progression-free survival compared to those treated with anastrozole (16.6 months vs. 13.8 months, p = 0.048).

However, subgroup analysis showed an even greater impact on progression-free survival in patients whose disease had not spread to the liver or lungs at baseline (22.3 vs. 13.8 months).

Study's principle investigator Matthew Ellis said, "For patients with non-visceral disease whose life isn't immediately threatened by breast cancer - a group for whom physicians would typically choose endocrine therapy as a first approach - it looks like fulvestrant could be a new standard of care compared to anastrozole."

Both groups showed a similar health-related quality of life and the most common adverse events were arthralgia (joint pain) (16.7 percent vs. 10.3 percent) and hot flushes (11.4 percent vs. 10.3percent) for fulvestrant and anastrozole, respectively.

"It's tolerated as well as anastrozole, and better than other drugs that could potentially be used in this setting such as chemotherapy or CDK4 inhibitors," Ellis said.

Adding, "In patients for whom you are looking for a low toxicity approach, such as older patients or those with low volume disease, it looks like a good option."

Researchers also observed a significantly greater duration of response to treatment in the fulvestrant group compared to the anastrozole group, which Ellis suggested could account for the increase in progression-free survival. (ANI)

London [UK], Mar. 23 (ANI): Want happy families? Then delay your decision to start a family, as a study suggests, children born to older mother experience have fewer behavioural, social and emotional problems.

Full Story >>

Washington D.C. [USA], Mar. 23 (ANI): For women, stay fit and maintain a healthy weight, as a study finds a higher waist-to-hip ratios increases the risk of ovarian cancer risk by more than a fifth.

Full Story >>

Washington D.C. [USA], Mar. 23 (ANI): A study finds that people who are born blind have heightened sense of hearing, smell and touch, suggesting that their brain "rewires" itself in the absence of visual information to boost other senses.

Full Story >>

New Delhi [India], Mar. 23 (ANI): For those suffering with age-related (degenerative) arthritis of the knee, a stage comes when all the reasonable non-operative options stops working.

Full Story >>

Hepatitis drug can help cut Ebola death rate

Updated: Mar 22, 2017 09:30 IST

Washington D.C. [USA], Mar. 22 (ANI): A class of drugs used to treat hepatitis and some forms of multiple sclerosis has shown promise in treating Ebola.

Full Story >>

Weekend surgery 'not riskier'

Updated: Mar 22, 2017 09:20 IST

Washington D.C. [USA], Mar. 22 (ANI): Day of the week has no impact on the survival chances of people undergoing emergency surgery, a new research has found.

Full Story >>

Washington D.C. [USA], Mar. 22 (ANI): Despite existing prevention methods, transmission of infections with HIV, hepatitis B, syphilis or rubella from mother to child before and during birth as well as in infancy still occur across Europe.

Full Story >>

Changes in blood may spur Alzheimer's disease

Updated: Mar 22, 2017 07:29 IST

Washington D.C. [USA], Mar. 22 (ANI): A recent study has linked changes in the vascular system to Alzheimer's disease.

Full Story >>

Spraying onto broken hearts to heal them

Updated: Mar 22, 2017 06:45 IST

Washington D.C. [USA], Mar. 22 (ANI): A team of scientist has come up with a new method that may make the heart surgeries a history.

Full Story >>

Washington D.C. [USA], Mar. 22 (ANI): With both tourism and casual "hookup" sex on the rise among college-age adults, there's an urgent need for gender-sensitive and age-appropriate sexual health campaigns that are tailored to young women's motivations for taking sexual risks while travelling, a new study has suggested.

Full Story >>

Washington D.C. [USA], Mar. 21 (ANI): Now, detecting a mosquito-borne illness will be as easy as clicking a smartphone app - thanks to a team of scientists.

Full Story >>

Washington D.C. [USA], Mar. 21 (ANI): A team of researchers has shed some light on how infections during pregnancy may interfere with the genes linked to prenatal brain development.

Full Story >>

Soon, a faster way to treat depression

Updated: Mar 21, 2017 16:02 IST

Washington D.C. [USA], Mar. 21 (ANI): A new and faster way to treat depression has come closer to reality - thanks to a team of scientists.

Full Story >>

All you need to know on Colorectal Cancer!

Updated: Mar 21, 2017 08:00 IST

New Delhi [India], Mar. 21 (ANI): Colorectal cancer is also known as colon cancer, bowel cancer. It refers to a cancerous growth, lump or a tumour in the colon and the rectum. It is the second most common cancer, after adenocarcinoma.

Full Story >>

Prevent yourself from chronic kidney disease!

Updated: Mar 21, 2017 07:50 IST

New Delhi [India], Mar. 21 (ANI): Each person normally has two kidneys, which are about the size of a fist and are located on either side of the spine at the level of waist.

Full Story >>

Washington D.C. [USA], Mar. 20 (ANI): In over-weight people, immune cells prevalent in the fatty tissue get reduced in number which may contribute to cause diabetes and hypertension, according to a recent study.

Full Story >>

Washington D.C. [USA], Mar. 20 (ANI): A study finds that by combining two independent, scientifically-proven risk measurements, physicians can better predict a patient's irregular and often very fast heart rate risk of stroke or death.

Full Story >>

Washington D.C. [USA], Mar. 19 (ANI): According to a recent study, pulmonary embolism (PE) treatments have low rates of use across the United States.

Full Story >>

Washington D.C. [USA], Mar. 19 (ANI): An advanced form of image-guided radiation therapy, known as intensity modulated proton therapy (IMPT), has shown early promise for the treatment of recurrent lung cancer.

Full Story >>

Washington D.C. [USA], Mar. 19 (ANI): Tennis elbow sufferers, if the idea of going under the knife is terrifying, then you can opt for non-operative approaches as a recent study has suggested that surgery may not offer additional benefit.

Full Story >>